SBI Securities
NVCR icon

SBI Securities’s NovoCure NVCR Stock Holding History

SBI Securities’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Sell
1,868
-147
-7% -$2.22K ﹤0.01% 1411
2026
Q1 		$22K Buy
2,015
+222
+12% +$2.77K ﹤0.01% 1417
2025
Q4 		$23.2K Buy
1,793
+168
+10% +$2.16K ﹤0.01% 1375
2025
Q3 		$21K Buy
1,625
+312
+24% +$4.17K ﹤0.01% 1430
2025
Q2 		$23.4K Buy
1,313
+84
+7% +$1.46K ﹤0.01% 1355
2025
Q1 		$21.9K Sell
1,229
-1,112
-48% -$25.3K ﹤0.01% 1297
2024
Q4 		$69.8K Buy
+2,341
New +$49.5K ﹤0.01% 873

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

SBI Securities's NVCR Position: Q2 2026 in Review

SBI Securities reduced its NovoCure (NVCR) stake by 7.3% in Q2 2026, selling an estimated $2.22K and leaving 1,868 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

SBI Securities first reported a position in NVCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $69.8K in Q4 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • SBI Securities held 1,868 shares of NovoCure worth $28.3K as of Q2 2026.
  • SBI Securities sold 147 NovoCure shares in Q2 2026, an estimated $2.22K.
  • NovoCure made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1411 holding.
  • SBI Securities first reported a position in NovoCure in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's NovoCure position peaked at $69.8K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.